Updates on Blood Cholesterol: Applying New Guidelines to Clinical Practice

Format: Webinar

Credit(s): 0.25 (15 min)

Release Date: Sep 18, 2019

Expiration Date: Nov 05, 2019

Credit Type(s):

PROGRAM OVERVIEW

AGENDA

Welcome and Introductions
Assessing ASCVD Risk – Role of LDL-C
Managing LDL-C to Lower ASCVD Risk
Q&A Session and Activity Roundup

TARGET AUDIENCE

This activity is intended for primary care clinicians, cardiologists, and other clinicians who manage patients who are at risk for or have ASCVD.

EDUCATIONAL OBJECTIVES

At the conclusion of this activity, participants should be able to:

Use guideline-recommended tools to evaluate the need for blood cholesterol management for primary ASCVD prevention in patients without clinical ASCVD
Implement the 2018 cholesterol guidelines when developing individualized primary prevention strategies for patients with and without severe hypercholesterolemia
Develop management plans for the secondary prevention of ASCVD using recommendations from the 2018 blood cholesterol guidelines
Intensify LDL-C management using adjunctive non-statin therapy when secondary prevention with statins alone does not achieve 2018 blood cholesterol guideline goals

ACCREDITATION

In support of improving patient care, this activity has been planned and implemented by the National Lipid Association and Rockpointe Corporation. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For information about the accreditation of this program, please email cme@lipid.org.

CREDIT DESIGNATION

PHYSICIAN CREDIT DESIGNATION
The National Lipid Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSISTANTS CREDIT DESIGNATION
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

PHARMACISTS CREDIT DESIGNATION
Universal Activity Number: JA0007192-9999-19-041-L01-P (Knowledge).

This activity has been approved for 1.00 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

NURSES CREDIT DESIGNATION
The maximum number of hours awarded for this CE activity is 1.0 contact hours.

FACULTY

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA Professor of Medicine, Cardiology Director, Seinsheimer Cardiovascular Health Program Co-Director, Women's Heart Care Medical University of South Carolina Charleston, SC

Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA is Professor of Medicine and Cardiology at The Medical University of South Carolina, where she serves as Medical Director of the Seinsheimer Cardiovascular Health Program and Co-Director of Women’s Heart Care. Dr. Morris is a fellow of the American College of Cardiology, the American Heart Association, the American Society of Preventive Cardiology, and the National Lipid Association. She is on the Executive Committees of the National Lipid Association and the American Board of Clinical Lipidology. She has been selected as Vice-Chair (2019-2020) and Chair (2021-2022) of the American College of Cardiology Annual Scientific Sessions. She also serves as Associate Editor of the Journal of the American College of Cardiology.

James A. Underberg, MD, MS, FNLA Past-President, National Lipid Association President, American Board of Clinical Lipidology Clinical Assistant Professor of Medicine NYU School of Medicine NYU Center for Prevention of Cardiovascular Disease Director, Bellevue Hospital Lipid Clinic New York, NY

James A. Underberg, MD, MS, FNLA is a clinical lipidologist and a Clinical Assistant rofessor of Medicine at the NYU School of Medicine and the NYU Center for Prevention of Cardiovascular Disease. He is also the Director of the Bellevue Hospital Lipid Clinic. Dr. Underberg is a Diplomate of the American Board of Clinical Lipidology and a Fellow and Past-President of the National Lipid Association (NLA). He is a board member for the NLA and the Foundation of the NLA, as well as the President of the American Board of Clinical Lipidology. Dr. Underberg’s clinical interests focus on the management of patients with lipids and lipoprotein disorders, the management of hypertension, and the prevention of cardiovascular disease. He maintains an active clinical research program in these areas and has authored numerous articles and book chapters in the field of clinical lipidology. He sees patients both at Bellevue Hospital and in a university-based private-practice setting.

Kim K. Birtcher, MS, PharmD, AACC, FNLA, BCPS-AQ Cardiology, CDE Clinical Professor University of Houston College of Pharmacy Houston, TX

Kim K. Birtcher, MS, PharmD, AACC, FNLA, BCPS-AQ Cardiology, CDE is a Clinical Professor at the University of Houston College of Pharmacy. She is also a clinical pharmacist in Kelsey-Seybold Clinic’s Cardiology Clinic in Houston, TX, where she is responsible for the Secondary Prevention Lipid Clinic. Her teaching and research interests are in cardiovascular risk reduction and quality improvement initiatives. Dr. Birtcher received her bachelor's in pharmacy and master's in pharmacy administration from the University of Texas at Austin. She received her Doctor of Pharmacy from the University of Florida. Dr. Birtcher is a certified diabetes educator and board-certified pharmacotherapy specialist with additional qualifications in cardiology. She is an Associate of the American College of Cardiology and a Fellow of the National Lipid Association. Dr. Birtcher is an active member of the American College of Cardiology, having served on many committees, and a member of the Southwest Lipid Association.

Lynne T. Braun, PhD, CNP, FAHA, FPCNA, FAANP, FNLA, FAAN Professor of Nursing and Medicine Nurse Practitioner, Rush Heart Center for Women LaGrange, IL

Lynne T. Braun, PhD, CNP, FAHA, FPCNA, FAANP, FNLA, FAAN is a Professor in the Department of Adult Health and Gerontological Nursing, Rush University College of Nursing, as well as a Professor in the Department of Internal Medicine, Rush University Medical Center. She is a nurse practitioner in the Rush Heart Center for Women, where she focuses on prevention. Dr. Braun’s clinical and research interests include cardiovascular risk reduction, exercise, cardiac rehabilitation, hyperlipidemia, and hypertension management. Dr. Braun holds a PhD in Nursing Science from the University of Illinois at Chicago. She is board-certified as an Adult Nurse Practitioner from the ANCC. She is also a Diplomate of the Accreditation Council of Clinical Lipidology. Dr. Braun served as co-investigator for three research grants funded by the National Institutes of Health, most recently the study, "Reducing Health Disparity in African American Women: Adherence to Physical Activity." She is a co-author of five AHA/ACC Scientific Statements, the AHA/ACC statement on Performance Measures for the Primary Prevention of Cardiovascular Disease, and three AHA clinical practice guidelines, including the 2018 Multi-Society Guideline on the Management of Blood Cholesterol. She chaired the AHA policy statement on palliative care in cardiovascular disease and stroke. She has served as consultant to the CDC's Division for Heart Disease and Stroke Prevention for several projects. Dr. Braun is an editorial board member for the Journal of Clinical Lipidology; she serves as reviewer for numerous other journals. Dr. Braun is an elected Fellow of the American Academy of Nursing, the American Heart Association, the Institute of Medicine of Chicago, the National Lipid Association, the American Association of Nurse Practitioners, and the Preventive Cardiovascular Nurses Association.